Omics Analysis Services for Brain Tumors

The development of brain tumors is often linked to genetic mutations or alterations, but the mechanisms behind its onset and progression still remain unclear. Omics represents a high-throughput screening technology that obtains a snapshot of the underlying biology within an organism, which plays a significant role in promoting the study of human diseases. At Alfa Cytology, we offer comprehensive analyses of omics services to help our clients better research brain oncology.

Overview of Omics

Omics provides comprehensive profiling of biological components on a larger scale during brain tumor progression, which plays a crucial role in unraveling the molecular mechanisms of brain tumors and promotes the advancement of novel therapies. Through the integration of diverse omics analyses encompassing genomics, transcriptomics, proteomics and metabolomics, researchers are able to unveil intricate perspectives and gain profound insights into the biological mechanisms underlying brain tumors.

Multiple omics data types. Fig.1 Multiple omics data types and approaches to disease research. (Hasin Y., et al., 2017)

Our Services

Alfa Cytology offers diverse omics services including genomics, epigenomics, transcriptomics, metabolomics, proteomics, imaging omics and single cell sequencing tailored to your brain tumor biomarker discovery and therapeutics innovation.

Genomics Analysis for Brain Tumors

Brain tumor genomics such as whole genome sequencing and whole exome sequencing helps researchers investigate genetic mutations like single nucleotide variants, insertions, deletions and structural variants during the progression of brain tumors.

Epigenomics Analysis for Brain Tumors

We offer advanced epigenomics analysis encompassing DNA methylation sequencing, histone modification detection and non-coding RNA identification, aiming to facilitate the development of potential therapeutics for brain tumors.

Transcriptomic Analysis for Brain Tumors

We provide our clients with cutting-edge transcriptomics services including whole transcriptome sequencing, spatial transcriptomics analysis and targeted sequencing for brain tumors, aiming to shed light on gene expression patterns.

Metabolomics Analysis for Brain Tumors

Our metabolomics services enable researchers to dive deep into the dynamic metabolite changes during specific stages of tumor progression and facilitate the identification of novel biomarkers.

Proteomics Analysis for Brain Tumors

We apply a variety of technologies to provide our clients with spatial proteomics and protein microarray services to study the post-translational modification and protein-protein interaction during the progression of brain tumors.

Imaging Omics Analysis for Brain Tumors

Our brain tumor imaging omics services empower researchers by extracting and transforming high-throughput quantitative features from medical images into high-dimensional data, which facilitates the exploration of underlying genetic mutations of brain tumors.

In addition, Alfa Cytology also offers advanced single-cell sequencing for brain tumors to profile individual cells at molecular levels, encompassing genomics, epigenomics, transcriptomics, metabolomics and proteomics, which provides a detailed understanding of cellular heterogeneity tailored to brain tumor research.

Why Choose Us?

Customized
Solutions

In-depth
Analysis

Strong
Expertise

Short
Turnaround

At Alfa Cytology, we provide professional omics services and a comprehensive molecular landscape of brain tumors to meet different needs of our clients. Through the utilization of our cutting-edge omics analysis services, we aim to offer a novel insight into the fundamental biology of brain tumors and facilitate the discovery of potential therapeutics. If you are interested in our omics services, feel free to contact us.

Reference

Hasin Y.; et al. (2017). Multi-omics approaches to disease[J]. Genome biology. 18(1), 83.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.